Effect of low dose Semaglutide in people with Type 1 Diabetes and excess weight

Simple item page
dc.contributor.authorGrassi, Bruno A.
dc.contributor.authorOnetto, Maria Teresa
dc.contributor.authorSanchez, Camila
dc.contributor.authorTapia, Nicole
dc.contributor.authorMena, Francisca
dc.date.accessioned2025-01-20T17:06:19Z
dc.date.available2025-01-20T17:06:19Z
dc.date.issued2024
dc.description.abstractObesity is a prevalent problem in people living with T1D (PwT1D), and it has been linked to cardiovascular disease in this population. The use of low dose weekly Semaglutide (0,5 mg) was evaluated in a cohort of PwT1D and excess weight.
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.diabres.2024.111593
dc.identifier.eissn1872-8227
dc.identifier.issn0168-8227
dc.identifier.urihttps://doi.org/10.1016/j.diabres.2024.111593
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/90777
dc.identifier.wosidWOS:001201775200001
dc.language.isoen
dc.revistaDiabetes research and clinical practice
dc.rightsacceso restringido
dc.subjectType 1 Diabetes
dc.subjectObesity
dc.subjectGLP-1 receptor agonists
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleEffect of low dose Semaglutide in people with Type 1 Diabetes and excess weight
dc.typeartículo
dc.volumen209
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas